Andriyan Grinev

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. doi request reprint Development of a microarray-based assay for rapid monitoring of genetic variants of West Nile virus circulating in the United States
    Andriyan Grinev
    Laboratory of Emerging Pathogens LEP, Division of Emerging and Transfusion Transmitted Diseases DETTD, Office of Blood Research and Review OBRR, Center for Biologics Evaluation and Research CBER, Food and Drug Administration FDA, Silver Spring, MD, United States Electronic address
    J Virol Methods 239:17-25. 2017
  2. pmc Genetic analysis of West Nile virus isolates from an outbreak in Idaho, United States, 2006-2007
    Andriyan Grinev
    Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Int J Environ Res Public Health 10:4486-506. 2013
  3. doi request reprint Microarray-based assay for the detection of genetic variations of structural genes of West Nile virus
    Andriyan Grinev
    Laboratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Rockville, MD 20852, USA
    J Virol Methods 154:27-40. 2008
  4. pmc Evolutionary dynamics of West Nile virus in the United States, 1999-2011: phylogeny, selection pressure and evolutionary time-scale analysis
    Germán Añez
    Laboratory of Emerging Pathogens, DETTD OBRR CBER, US Food and Drug Administration, Bethesda, Maryland, USA
    PLoS Negl Trop Dis 7:e2245. 2013
  5. pmc Genetic Variability of West Nile Virus in U.S. Blood Donors from the 2012 Epidemic Season
    Andriyan Grinev
    Laboratory of Emerging Pathogens LEP, Division of Emerging and Transfusion Transmitted Diseases DETTD, Office of Blood Research and Review OBRR, Center for Biologics Evaluation and Research CBER, Food and Drug Administration FDA, Silver Spring, Maryland, United States of America
    PLoS Negl Trop Dis 10:e0004717. 2016
  6. pmc Genetic variability of West Nile virus in US blood donors, 2002-2005
    Andriyan Grinev
    Food and Drug Administration, Bethesda, Maryland, USA
    Emerg Infect Dis 14:436-44. 2008
  7. pmc Anti-West Nile virus activity of in vitro expanded human primary natural killer cells
    Mingjie Zhang
    Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20892, USA
    BMC Immunol 11:3. 2010
  8. doi request reprint Application of a full-genome microarray-based assay for the study of genetic variability of West Nile virus
    Andriyan Grinev
    Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, US Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, USA
    J Virol Methods 183:219-23. 2012
  9. pmc The global ecology and epidemiology of West Nile virus
    Caren Chancey
    United States Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD 20993 0002, USA
    Biomed Res Int 2015:376230. 2015
  10. ncbi request reprint Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion
    Maria Rios
    Laboratory of Molecular Virology LMV, Division of Emerging Transfusion Transmitted Diseases DETTD, Center for Biologics Evaluation and Research CBER, Food and Drug Administration FDA, Bethesda, MD 20892, USA
    Transfusion 46:659-67. 2006

Collaborators

Detail Information

Publications11

  1. doi request reprint Development of a microarray-based assay for rapid monitoring of genetic variants of West Nile virus circulating in the United States
    Andriyan Grinev
    Laboratory of Emerging Pathogens LEP, Division of Emerging and Transfusion Transmitted Diseases DETTD, Office of Blood Research and Review OBRR, Center for Biologics Evaluation and Research CBER, Food and Drug Administration FDA, Silver Spring, MD, United States Electronic address
    J Virol Methods 239:17-25. 2017
    ..The methods were evaluated using WNV isolates from the 1999-2012U.S. epidemics...
  2. pmc Genetic analysis of West Nile virus isolates from an outbreak in Idaho, United States, 2006-2007
    Andriyan Grinev
    Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Int J Environ Res Public Health 10:4486-506. 2013
    ..Continued monitoring of new genetic variants is important for public health as WNV continues to evolve. ..
  3. doi request reprint Microarray-based assay for the detection of genetic variations of structural genes of West Nile virus
    Andriyan Grinev
    Laboratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Rockville, MD 20852, USA
    J Virol Methods 154:27-40. 2008
    ....
  4. pmc Evolutionary dynamics of West Nile virus in the United States, 1999-2011: phylogeny, selection pressure and evolutionary time-scale analysis
    Germán Añez
    Laboratory of Emerging Pathogens, DETTD OBRR CBER, US Food and Drug Administration, Bethesda, Maryland, USA
    PLoS Negl Trop Dis 7:e2245. 2013
    ....
  5. pmc Genetic Variability of West Nile Virus in U.S. Blood Donors from the 2012 Epidemic Season
    Andriyan Grinev
    Laboratory of Emerging Pathogens LEP, Division of Emerging and Transfusion Transmitted Diseases DETTD, Office of Blood Research and Review OBRR, Center for Biologics Evaluation and Research CBER, Food and Drug Administration FDA, Silver Spring, Maryland, United States of America
    PLoS Negl Trop Dis 10:e0004717. 2016
    ..S. continued to increase in 2012, and that closely related variants were found across a broad geographic range of the U.S., coincident with the second-largest WNV outbreak in U.S. ..
  6. pmc Genetic variability of West Nile virus in US blood donors, 2002-2005
    Andriyan Grinev
    Food and Drug Administration, Bethesda, Maryland, USA
    Emerg Infect Dis 14:436-44. 2008
    ..37%), suggesting absence of strong selective pressure and limited genetic evolution of WNV during that period. Nevertheless, WNV has continued to diverge from precursor isolates as geographic distribution of the virus has expanded...
  7. pmc Anti-West Nile virus activity of in vitro expanded human primary natural killer cells
    Mingjie Zhang
    Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20892, USA
    BMC Immunol 11:3. 2010
    ..The expanded NK cells were tested for their ability to inhibit WNV infection in vitro...
  8. doi request reprint Application of a full-genome microarray-based assay for the study of genetic variability of West Nile virus
    Andriyan Grinev
    Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, US Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, USA
    J Virol Methods 183:219-23. 2012
    ..S. epidemics. The developed microarray system can potentially serve as a high throughput, rapid, and effective approach for the detection of circulating WNV genetic variants...
  9. pmc The global ecology and epidemiology of West Nile virus
    Caren Chancey
    United States Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD 20993 0002, USA
    Biomed Res Int 2015:376230. 2015
    ..Surveillance and preventive measures are an ongoing need to reduce the public health impact of WNV in areas with the potential for transmission. ..
  10. ncbi request reprint Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion
    Maria Rios
    Laboratory of Molecular Virology LMV, Division of Emerging Transfusion Transmitted Diseases DETTD, Center for Biologics Evaluation and Research CBER, Food and Drug Administration FDA, Bethesda, MD 20892, USA
    Transfusion 46:659-67. 2006
    ..Whether primary monocyte-derived macrophages (MDMs) support WNV infection-replication and produce infectious virions, with an in vitro system, was investigated...
  11. pmc Complete Genome Sequence of West Nile Virus Strains Used for the Formulation of CBER/FDA RNA Reference Reagents and Lot Release Panels for Nucleic Acid Testing
    Andriyan Grinev
    Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U S Food and Drug Administration, Bethesda, Maryland, USA
    Genome Announc 2:. 2014
    ..We report the complete sequences of two West Nile virus strains (FDA-Hu02 and NY99) used for the formulation of CBER/FDA RNA reference reagents and lot release panels for use with nucleic acid technology testing. ..